Once we know the specific peptides from the algorithm, it will be easier to expand the peptide specific CD8 + T cells and characterize their T cell receptors for subsequent development of TCR engineered CD8 + T cells for cancer immunotherapy [47]. Here, CD8A is linked to cancer.